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Background: Step tests have been used to evaluate exercise tolerance and effort-related hyp-
oxemia in different diseases. A symptom-limited incremental step test (IST) has never been
tested in COPD patients.
Aim: To compare maximal physiological responses between an IST and cardiopulmonary exer-
cise testing (CPET), to test the reproducibility of the IST on different days, and to provide a
predict equation to estimate VO2 from the IST in patients with COPD.
Material and methods: At the same day, thirty-four patients (VEF1 46  14% of pred) under-
went a CPET on cycle ergometer and the first IST (IST-1) (1 h apart). After 2e5 days, patients
repeated the IST (IST-2). Pulmonary gas exchange was measured during all tests.
Results: Peak VO2 was significantly higher in IST-1 and IST-2 than in CEPT (Mean  SD:
1.19  0.39 L, 1.20  0.40 L, 1.07  0.35 L) with no difference for ventilation (VE), heart rate
(HR), and perception of effort. ISTs were highly reproducible, with significant intraclass corre-
lation coefficient (CCI [95% confidence interval]) for number of steps (0.98[0.95e0.99]), VO2
(0.99 [0.98e0.99]), VE (0.97[0.93e0.99]), HR (0.92[0.81e0.97]), and SpO2 (0.96[0.90e0.98]).
Desaturation was significantly higher for IST-1 and IST-2 compared with cycling (Mean  SD:a poster discussion at the American Thoracic Society Congress, 2009, San Diego, and at the European
msterdam.
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1994 S. Dal Corso et al.6  5%, 6  4%, 3  3%). Number of steps and patient weight explained 81% of the
variance in peak VO2 (p < 0.001).
Conclusion: A symptom-limited incremental step test, externally paced, elicits maximal car-
diopulmonary and metabolic responses, and is well tolerated and reproducible in patients with
COPD.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
In addition to systemic manifestations, the main conse-
quence arising from chronic obstructive pulmonary disease
(COPD) is the exercise intolerance. Cardiopulmonary ex-
ercise testing (CPET) remains the gold standard to assess
patient’s exercise capacity [1], but its use is limited in
clinical practice. Hence walk tests have been widely used
in subjects with cardiopulmonary diseases for this purpose
[2] and as a complement to laboratory-based tests [3]
because desaturation occurs during walking but not
cycling in a subgroup of patients [4]. In terms of pulmonary
function, the patients who presented desaturation on the
6MWT and CPET had greater total lung capacity in
comparison with those who presented desaturation only
during the 6MWT [4]. The mechanisms involved in this
phenomenon are not yet completely understood, and it is
speculated that it occurs due to differences in the venti-
latory demand and muscle mass used during cycling and
walking.
While walk tests such as the 6MWT and shuttle walk test
require corridors free from transit, 30 and 10 m in length,
respectively, for appropriate execution, the step test is a
feasible alternative for evaluating exercise capacity, due to
its portability.
The first description of the step test in COPD was in the
mid-1980s and it elicited higher ventilation and oxygen
uptake (VO2) in comparison with walking and cycling [5].
The protocol used by Swinburn et al. [5] could be
considered a constant workload test as the stepping rate
was kept constant (15 steps per minute) throughout the
test. The same should be considered for the 6-min step-
per test [6], as it is self-paced and limited by time.
Therefore, these tests do not allow evaluation of car-
diopulmonary responses to the progressive increase in
demand.
Recently, our group compared exercise tolerance and
physiological responses between two different incremental
step test protocols [7]. A longer duration and a higher
number of steps were obtained in the symptom-limited
incremental step test. However, it is still unknown
whether this test determines maximum physiological re-
sponses in patients with COPD. Therefore, the objectives of
this study were (i) to analyze whether a symptom-limited
incremental step test determines maximum physiological
responses, and secondarily, (ii) to test the reproducibility
of the step test performed on different days, (iii) to
compare exercise-induced desaturation between stepping
and cycling in patients with COPD, and (iv) to provide a
prediction equation for estimating the oxygen uptake
(VO2).Methods
Subjects
Thirty-four consecutive male subjects with moderate-to-
severe COPD [8] were studied. The subjects were clinically
stable, their medications had not changed during the study,
and they presented resting oxygen saturation higher than
90% in room air. No subjects were receiving medications
that could affect exercise responses. Subjects with any
musculoskeletal condition that could limit their participa-
tion in performing the tests were excluded. Written,
informed consent was obtained from all subjects, and the
Ethics Committee of the Universidade Nove de Julho
approved the study (182476).
Study design
Subjects were tested on two occasions. On the first day, the
subjects underwent CPET, and after an hour of rest, they
performed the first incremental step test (IST-1). Depend-
ing on the availability of the patients, they returned two to
five days later to repeat the step test (IST-2). Before car-
rying out the first step test, a 1-min period of practice was
held for familiarization with the step rhythm. All tests were
performed at room air. The primary outcomes were VO2 and
number of steps.
Maximal cardiopulmonary exercise testing
The CPET test was carried out on an electromagnetically
braked cycle ergometer (Corival; Lode B.V. Medical Tech-
nology, Groningen, Netherlands). After 2 min at rest and
2 min more cycling at zero workload, the power was
continuously increased in a linear ramp pattern (5e15 W/
min). Pulmonary gas exchange and ventilatory variables
were recorded breath-by-breath and expressed as 20s-
mean. Peak VO2 was expressed in absolute and predict
values [9].
Incremental step test
The subjects stepped up and down on a 20 cm high wooden
bench (width 40 cm, depth 60 cm). The stepping rate was
dictated by an audio signal played on a compact disc. The
initial stepping rate was 10 steps/min with increments of
one-step every 30 s up to the limit of tolerance [7,10]. It
was allowed to use a handrail if the patient so preferred. In
patients who opted for this strategy, the test was repeated
in the same way. The criteria for stopping the test were
Table 1 Characteristics of the study group (n Z 34).
Variables Mean  SD Range
Age (yrs) 67  9 49e83
BMI (kg/m2) 25.8  4.3 18.8e34.5
FVC (L) 3.1  0.7 1.8e4.8
FVC (% predicted) 85  15 57e117
FEV1(L) 1.3  0.4 0.7e1.3
FEV1 (% predicted) 46  14 23e77
FEV1/FVC 42  8 28e60
MVV (L) 52  17 28.4e101.2
BMI; body mass index, FVC; forced vital capacity, FEV1; forced
expiratory volume in 1 s, MVV; maximal voluntary ventilation.
Figure 1 Bland and Altman plots for VO2 at the peak of CPET
and IST (top panel) and for VO2 at the peak of the two ISTs
(bottom panel). The dark line corresponds to the average dif-
ference whereas the dotted lines correspond to lower and
upper limits of agreement.
Step test in patients with COPD 1995intolerable symptoms of dyspnea and/or fatigue and the
patient’s inability to keep the pace for a period of 15 s [7].
The vertical distance was calculated by multiplying the high
of the step (0.20) by the number of steps. The performance
on IST was compared between patients with lower and
higher severity of disease (forced expiratory volume in the
first second Z FEV1 50% and <50% of the predicted
values, respectively).
Physiologic measures
During all tests, gas exchange parameters were analyzed
breath-by-breath (CPX Ultima, Medical Graphics Corpora-
tion, St. Paul, MN). ECG tracings and heart rate (HR) were
recorded continuously. Maximal voluntary ventilation (MVV)
was estimated by FEV1  40 [11]. Pulse oximetric saturation
(SpO2) was measured (Model 7500; Nonin, Plymouth, MN).
Change in SpO2 between rest and exercising 4 was
considered desaturation [12].
Perception of effort
The subjects were asked to rate dyspnea and leg fatigue at
exercise cessation by using the 0e10 Borg’s category-ratio
scale [13].
Statistical analysis
The results were expressed as mean  SD. We used one-way
repeated measures analysis of variance for comparisons
among variables of the two ISTs and the CPET. Intraclass
correlation coefficient (ICC) and 95% confidence interval
(95% CI) were used to verify the reproducibility between
IST-1 and IST-2 for number of steps and peak VO2, ventila-
tion (VE), HR, and SpO2. In addition, Bland-Altman analysis
was used to compare the two ISTs and the best IST (the test
with the greater number of steps climbed) and CPET. Un-
paired t-test was used to compare the performance on IST
between patients with lower and higher severity of disease.
Pearson correlation coefficient was used to correlate the
independent variables (age, weight, height, and number of
steps) with the dependent variable (VO2). A multiple linear
regression analysis (stepwise) was performed to define a
predictive equation for VO2 from IST considering the same
independent variables. The level of statistical significance
was set at p < 0.05. Statistical tests were performed using
the Statistical Package for the Social Sciences version 13.0,
2004 (SPSS, Chicago, IL).
Results
Demographic and lung function data of the subjects are
summarized in Table 1.
There were no significant differences in the gas ex-
change variables and subjective dyspnea and fatigue at rest
among IST-1, IST-2, and CPET. At peak exercise, VO2 (Fig. 1,
top panel) and desaturation were significantly higher in
both step tests compared with CPET, with no difference for
the other variables (Table 2). Desaturation was detected
only during the step test in 29% of the subjects. Consideringpulmonary function, patients with lower disease severity
(FEV1 50% predicted) showed higher performance at IST
than patients with higher severity (FEV1 <50% predicted)
(142  66 steps vs. 84  40 steps, respectively; pZ 0.004).
The majority of the subjects (n Z 23) had their best
performance on the IST-2; ten patients had their best
performance on the IST-1, and one patient had the same
performance on both step tests. The step tests were
reproducible with ICC analysis for number of steps [0.99
Table 2 Data at the peak exercise.
Variables CPET IST-1 IST-2
VO2 (L/min) 1.07  0.35* 1.19  0.39 1.20  0.40
VO2 (% predicted) 59  17 66  19 67  20
VCO2 (L/min) 1.11  0.40 1.14  0.42 1.16  0.46
Vt (L) 1.29  0.40 1.24  0.35 1.27  0.35
RR (rpm) 33  8 34  6 33  7
VE (L/min) 41.8  13.6 41.5  13.8 41.9  14.2
VE/VO2 39.9  8.5* 35.9  7.8 35.4  7.1
VE/VCO2 38.6  7.0 37.8  9.0 37.7  8.3
VE/MVV 0.82  0.14 0.81  0.13 0.82  0.14
HR (bpm) 144  21 134  21 132  21
% HR predicted 88  13 88  13 86  12
SpO2 (%) 90  4* 87  5 87  5
DSpO2 3  3* 7  5 7  5
Dyspnea 5.4  2.3 5.4  2.5 5.1  2.2
Fatigue 5.5  2.6 5.2  2.7 5.1  2.7
CPET e % predicted 55  24 e e
Number of steps (range) e 107  60 (37e269) 112  63 (32e276)
VO2; oxygen uptake, VCO2; pulmonary carbon dioxide production, Vt; tidal volume, RR; respiratory rate, VE; ventilation, VE/VO2;
ventilatory equivalent for O2, VE/VCO2; ventilatory equivalent for CO2, VE/MVV; ventilation to maximum voluntary ventilation, HR;
heart rate, SpO2; pulse oximetric saturation, CPET; cardiopulmonary exercise testing.
*p < 0.0001 CPET vs. StT-1 and StT-2.
1996 S. Dal Corso et al.(0.97e0.99)], VO2 [0.99 (0.98e0.995)], VE [0.97
(0.94e0.98)], HR [0.93 (0.85e0.96)], and SpO2 [0.97
(0.94e0.99)] and by the quite low bias from the
BlandeAltman analysis for VO2 (Fig. 1, bottom panel) and
other variables (Table 3). For number of steps, the mean
bias was also quite low, but with a wide lower and upper
limit of agreement (Fig. 2).
There were significant correlations between the VO2 in
the best IST and age (r Z 0.38, p Z 0.026), weight
(r Z 0.51, p Z 0.002), height (r Z 0.39, p Z 0.022), and
number of steps (r Z 0.79, p < 0.0001). Among the pa-
rameters correlated with peak VO2 in the univariate anal-
ysis, number of steps and patient weight remained
independent predictors after stepwise multiple regression
analysis (R2Z 0.81, p < 0.001). The data from the multiple
linear regression analysis are shown in Table 4.
Discussion
In the present study, we have shown that a symptom-
limited incremental step test determines maximumTable 3 Results from BlandeAltman analysis.





HR (bpm) 1.3 (18 to 20) 2.4 (19 to 24)
VE (L) 0.3 (11. to 12) 0.10 (9.5 to 5.1)
SpO2 (%) 3.6 (2.4 to 9.6) 0.03 (3 to 3)
a The best IST. CPET: cardiopulmonary exercise testing. IST:
incremental step test, HR: heart rate, VE: ventilation, SpO2:
pulse oximetric saturation.cardiopulmonary and metabolic responses, is reproducible,
and leads to more profound hypoxemia. In addition, num-
ber of steps and patient weight explained 81% of the vari-
ation of the peak VO2.
As with conventional exercise testing protocols per-
formed on treadmill and cycle ergometer, step tests can be
classified either incremental or constant workload. Pro-
tocols with progressively increasing rates of work are more
suitable when the clinical objectives are to quantify
maximal exercise capacity and evaluate the profile of
changes in the metabolic, cardiovascular, and ventilatory
variables. While there is a significant body of literature
comparing the physiologic responses between CPET and
walk tests, a symptom-limited incremental step test has
never been validated in patients with COPD. However whyFigure 2 BlandeAltman plot for number of steps.









Constant 221.576 552 to 109 0.181
No. of steps 4.833 3.8e5.9 0.745 <0.001 0.74
Weight 12.019 7.6e16.4 0.437 <0.001 0.44
VO2 pred (L): 221.576 þ (4.833  No. of steps) þ (12.019  patient weight).
Step test in patients with COPD 1997to purpose one more exercise testing if the literature is
replete of field tests for use in patients with cardiopulmo-
nary diseases? Walking tests are the most commonly used
for assessing of functional capacity, but they not neces-
sarily reflect the patient’s ability to perform another type
of exercise. It is possible that some patients do not
complain of walking limitations but have limitations with
stair climbing, as the latter is a more strenuous activity
[14]. The main issues with the stair climbing test are that
there is no standardization regarding how to perform it or
how the results should be expressed. More importantly, the
number of stairs per flight and the height of the stairs are
not the same in all rehabilitation centers, which compro-
mise the external validity of the test [15].
Maximum performance and portability are the main
advantages of IST over walking tests and stair-climbing
tests, which facilitate the evaluation of exercise capacity in
any environment. Thus, IST can serve as either laboratory-
based testing when pulmonary gas exchange is available, or
a field-based test when conducted outside of this context.
Thus, when a gas analysis system is available during the IST,
the main outcome might be VO2, and when the IST is per-
formed as a field test, the number of steps would be the
main outcome. Others advantages are the possibility of
performing the test using an electrocardiogram, as well as
measuring symptoms (dyspnea and fatigue) throughout the
test.
Given its incremental feature, it was expected that our
protocol would induce a similar cardiopulmonary response
at peak exercise as the CPET. We also anticipated higher
oxygen consumption during stepping, due to the greater
muscle mass involved in this activity, which is also more
overloaded by the constant vertical displacement of the
body. A previous study demonstrated a higher VO2 peak
(25%) during stepping than during cycling in patients with
COPD [5]. In our study, this difference was smaller (12%),
probably due to differences between the step-test pro-
tocols. The protocol described by Swinburn et al. [5] was
performed on a 25 cm platform with a fixed rate of 15
steps/minute, and patients were able to complete, on
average, less than 5 min of test, although its duration had
been fixed at 10 min. The range of the number of steps
climbed was lower than with our protocol (14e126 vs.
32e276, respectively). The fact that the patients dis-
continued the test early leads us to infer that the protocol
used by Swinburn et al. [5] determined an intense to very
intense effort. Thus, we speculate that the higher differ-
ence in peak VO2 between cycling and stepping in the
Swinburn study (25%) compared to ours (12%) occurred
because of the slow component of oxygen uptake kineticsin the former study. During constant workload exercise in a
heavy to very heavy intensity, the primary component of
VO2 kinetics is supplemented by an additional slow
component, which causes an excess of VO2 and a delay in
the steady state [16], justifying that no patient reached the
steady state for VO2 and VE, despite the stepping rate
being kept constant throughout the protocol used by
Swinburn et al. [5]
As observed previously in walking tests [17], the ma-
jority of patients achieved the best performance in the
second IST, which is also confirmed by the negative mean
difference in the BlandeAltman analysis (Table 3),
demonstrating that there is a learning effect. Beyond the
high ICC, the limits of agreement for oxygen uptake (from
0.17 mL to 0.15 mL) and saturation (from 3% to 3%) at
peak exercise are small enough for us to be confident in
high degree of reliability for cardiopulmonary responses
during both incremental step tests. The limits of agreement
were wider for number of steps (Table 4); for that reason, a
practice test is required. The Chester Step Test (CST) pre-
sented even smaller limits of agreement (20 to 18) for
number of steps [18]. Compared with our protocol, the CST
has a substantial increase in work rate (five steps every
2 min), and changes in work intensity have been related to
the magnitude of the perception of symptoms [19,20].
Therefore, ample changes in work intensity precipitates
the perceived exertion at the moment the test stage
changes, leading patients to discontinue the test at a
similar stage as that achieved in the previous test [18],
contributing to its high reproducibility. On the other hand,
despite being reproducible, the CST had a very short
duration in patients with COPD, which is not suitable for
assessing physiological responses during exercise.
The use of the step tests to evaluate oxygen desatura-
tion has been described previously in patients with lung
diseases [12,21,22]. However, to the best of our knowledge,
this is the first time desaturation is compared between a
step test and the CPET in patients with COPD. Patients
desaturate to a greater extent during IST. This finding is in
line with previous investigations that have shown that
desaturation is greater during walking field tests compared
to cycling [23,24]. Unlike the studies comparing cycling and
walking, the difference in the magnitude of desaturation
between stepping and cycling in the present study cannot
be attributed to dissimilarity in ventilatory responses,
because VE/VCO2 was similar among the tests. We specu-
late that the main component involved in greater desatu-
ration during stepping is the increased work that results
from the displacement of the body weight against gravity,
which leads to lower mixed venous oxygen saturation
1998 S. Dal Corso et al.compared to cycling. It is still unclear whether desaturation
levels in the walking tests and the incremental step test are
similar. Although a previous study showed a similar drop in
arterial oxygen pressure between walking (2.6 mmHg) and
stair climbing (2.4 mmHg) [14], another one [25] found
lower SpO2 levels in the 1-min stair step test than in the
6MWT (90.2  6.6 vs. 91.8  5.9, respectively; pZ 0.015).
It is interesting to point out that the former study selected
only patients with COPD in the severe and very severe
classifications (GOLD criteria), while the latter included
patients with different lung diseases.
The present study also demonstrated that number of
steps and patient weight are determinants of aerobic ca-
pacity assessed by the step test in patients with COPD. These
two variables entered in an equation used to estimate the
work performed during stair climbing (workZ step height in
meters  step/minute  weight in kg  0.1635) [26], and
number of steps is also a predict variable to estimate VO2
during stepping up and down on a single platform [27]. Our
study is the first to establish an equation to predict VO2 from
a step test in patients with COPD. A prospective application
of this equation to test its accuracy in predicting VO2 should
be tested in further studies.
Some limitations occurred in our study. The tests order
was not randomized. However, the similar physiological
responses at the peak of both ISTs demonstrate that the
CPET did not influence the first IST performed after CPET.
We did not test different step heights, but we believe
that this factor would only be important in extremes of
height (i.e., much taller and shorter individuals). The
higher values of peak VO2 obtained in the step test
compared to cycling demonstrates that this aspect was not
relevant to the patients evaluated in our study. Although
stepping performance (number of steps) was about 60% less
in patients with worse FEV1, we were unable to determine
whether the results of this test differed according to
varying degrees of COPD severity. In addition, it is not yet
clear whether the desaturation observed in the step test
correlates with that observed during daily living activities.
Although the IST elicited maximum physiological re-
sponses, this does not imply that it can replace the CPET, as
theCPET has reference values established for bothmaximum
exercise and dynamic responses, as well as the criteria for
determining cardiovascular, ventilatory, and peripheral
limitations. However, the IST can be a complementary
evaluation of exercise-induced hypoxemia. In addition, the
IST can be used to determine the intensity (number of steps)
of stepping training, which has been used as part of aerobic
training for patients with COPD [28e32]. Moreover, in the
context of rehabilitation, the number of steps performed on
IST could be used to quantify the responsiveness of in-
terventions to improve exercise tolerance.
In conclusion, a symptom-limited incremental step test
does elicit maximum cardiopulmonary and metabolic re-
sponses and is reproducible in patients with COPD.Authorship
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